Lipid Controls
Avanti Polar Lipids L-α-phosphatidylethanolamine (Brain, Porcine), 383907-18-4, MFCD02265857, 25 mg
Formula Weight: 768.610, Purity >99%, Stability: 3 Months, Storage Temperature: -20°C. Contains ~50% plasmalogen ether lipid.
Medchemexpress LLC Dodap | 127512-29-2 | MFCD01321074 | 98.0% | 648.05 g/mol | C41H77NO4 | 5 MG
DODAP is an ionizable cationic lipid used as the lipid component in liposomal formulations for nucleic acid delivery and related research. It is commonly employed to encapsulate siRNA and support intracellular delivery of therapeutic or immunostimulatory agents in vitro and in vivo, with applications in vaccine and inflammation studies.
- Cationic lipid that facilitates siRNA encapsulation and delivery.
- Ionizable with a pKa around 5.59 to aid endosomal release.
- High purity (98.0%) supplied as a liquid for formulation flexibility.
- Available in multiple pack sizes suitable for small-scale experiments.
- Defined storage conditions for long-term stability in pure form and in solvent.
Avanti Polar Lipids 18:1 PI(4,5)P2 | 799268-56-7 | MFCD22416812 | 100 ug
18:1 PI(4,5)P2 | Purity: 99% | Mol Wt: 1073.569 | 799268-56-7 | MFCD22416812 | 100 ug
Avanti Polar Lipids DOGS-NTA IN CHLOROFORM, 10MGD
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (nickel salt). 231615-77-3
Organix Inc DLIN-KC3-DMA
3-(2,2-di((9Z,12Z)-octadeca-9,12-dien-1-yl)-1,3-dioxolan-4-yl)-N,N-dimethylpropan-1-amine
Avanti Polar Lipids CER1 (D18:1/26:0/18:1(D9)) 1MG
N-[26-oleoyloxy(d9) hexacosanoyl]-D-erythro-sphingosine 1mg | Purity >99% | CAS 2260670-32-2 | Formula Weight: 967.670
Apexbio Technology LLC DMG-PEG2000-N3 50mg
DMG-PEG2000-N3 is a PEGylated lipid derivative utilized for the functionalization of lipid-based drug delivery systems It consists of 1 2-dimyristoyl-sn-glycerol (DMG) polyethylene glycol (PEG 2000 Da) and a terminal azide group (N3) The azide functional group enables selective conjugation via copper-catalyzed azide-alkyne cycloaddition (CuAAC or click chemistry) allowing controlled attachment of biomolecules small-molecule drugs fluorescent probes or targeting ligands onto lipid bilayers DMG-PEG2000-N3 is widely applied in the development of liposomal or nanoparticle formulations for targeted drug delivery and imaging in biomedical research
